Is Tirzepatide Oral or Injectable — and Does the Format Change Anything?

Why the format question matters before you decide anything else

It is a fair thing to want to know before you commit. Some people are fine with a weekly injection; others would strongly prefer a daily tablet if it were an option. The practical news is that for tirzepatide specifically, there is no decision to make on format right now in the UK. The MHRA has licensed tirzepatide as an injection (sold under the brand name Mounjaro) and that remains the only approved route of administration available from a UK pharmacy.

What the question often really signals is an underlying hesitation about needles or a preference for tablet-based treatment. Both are completely understandable. Needle anxiety is one of the things our prescribers hear about most weeks, and it is worth knowing that the KwikPen is designed to be used at home without clinical training, the needle is very fine and the mechanism covers it. Most people who were worried beforehand find the first injection far more straightforward than they expected. A practical check you can do right now: visit the step-by-step injection guide to see exactly what the process looks like before making any assumptions about whether you could manage it.

If a tablet genuinely suits you better, there is now a licensed oral GLP-1 medicine for weight management in the UK (see the treatment overview for details) but it uses a different active ingredient. Tirzepatide itself remains injectable only.

What the tirzepatide injection actually involves day to day

Understanding the format in concrete terms often removes the hesitation. The Mounjaro KwikPen is a pre-filled auto-injector: you select your dose, press it against your skin on the abdomen, thigh or upper arm, and the mechanism does the rest. Treatment begins at the 2.5 mg starter dose for the first four weeks. The starting dose exists to give your body time to adjust, the purpose is tolerability, not yet the full therapeutic effect. From there, the prescriber guides titration upward in four-week steps through 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, based on your response and how you are tolerating the medicine.

You inject once a week, on any day you choose, at a consistent time. If you want a full overview of how the medicine is administered and what to expect from each dose, the tirzepatide injection page covers the process in detail. The pen is kept in the fridge at 2–8°C; the full storage detail is in the Patient Information Leaflet and the Summary of Product Characteristics on the eMC, that is always the definitive reference for storage windows, not secondary sources. Used pens should go into a sharps bin rather than general waste. That is the practical shape of the treatment.

The NHS tirzepatide page covers common questions about the injection process, including missed doses and how to manage them, always the first port of call for those questions, alongside your prescriber.

Is oral tirzepatide coming to the UK, and what should you do in the meantime?

Eli Lilly has published phase 3 data on an oral tirzepatide formulation (the SURPASS-MONO and related oral trials), and the data look promising. However, promising trial data and a UK licence are different things. As of summer 2026, the MHRA has not approved an oral tirzepatide product for weight management or diabetes in the UK. No timeline for a UK submission has been announced publicly, and it would be wrong to give the impression that an approval is imminent.

What IS available in oral form for weight management is semaglutide (Wegovy tablets), which received MHRA approval in June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK. If that formulation interests you, comparing the evidence for the two active ingredients is a useful exercise, a detailed look at how they differ is available on the tirzepatide oral vs injection page, and a broader treatment comparison can be found at our weight-loss treatment overview.

If you are currently exploring tirzepatide because you have heard about it and want to know whether it might be appropriate for you, the most useful next step is a clinical assessment rather than further research. Which medicine suits you depends on your medical history, current medicines, BMI and weight-related conditions, details that a prescriber needs in front of them to give you a proper answer. You can read more about Mounjaro in the UK and how the treatment works before deciding whether to go ahead.